Mood and Anxiety Related Phenotypes in Mice
暂无分享,去创建一个
[1] S. Alonso,et al. Sex differences in behavioral despair: Relationships between behavioral despair and open field activity , 1991, Physiology & Behavior.
[2] R. Lister,et al. Effect of isolation on brain monoamines and the behavior of mice in tests of exploration, locomotion, anxiety and behavioral ‘despair’ , 1989, Pharmacology Biochemistry and Behavior.
[3] F. Liu,et al. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent , 2008, Neuropharmacology.
[4] O. Puciłowski,et al. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression , 1995, Psychopharmacology.
[5] D. Murphy,et al. Evaluation of Antidepressant-related Behavioral Responses in Mice Lacking the Serotonin Transporter , 2002, Neuropsychopharmacology.
[6] C. Beyer,et al. Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation , 2010, Psychopharmacology.
[7] Alan A. Wilson,et al. Bupropion occupancy of the dopamine transporter is low during clinical treatment , 2002, Psychopharmacology.
[8] R. Andreatini,et al. Animal models: Trait or state measure? The test-retest reliability of the elevated plus-maze and behavioral despair , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[9] S. Kayaalp,et al. Effect of changes in swimming area on results of “behavioral despair test” , 1994, Pharmacology Biochemistry and Behavior.
[10] M. Le Moal,et al. Abolition and reversal of strain differences in behavioral responses to drugs of abuse after a brief experience. , 2000, Science.
[11] M. Colombel,et al. [Enhancement of nociceptive reactions by naloxone in mice and rats (author's transl)]. , 1974, Psychopharmacologia.
[12] J. Besson,et al. A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in the rat. I. The production of behavioral side effects together with analgesia , 1984, Brain Research.
[13] Adrienne Z. Ables,et al. Antidepressants: update on new agents and indications. , 2003, American family physician.
[14] C. Nemeroff. Anxiolytics: past, present, and future agents. , 2003, The Journal of clinical psychiatry.
[15] M. Freedman,et al. The effects of serotonin antagonists in a behavioral despair procedure in mice. , 1984, European journal of pharmacology.
[16] F. Turek,et al. The circadian Clock mutation increases exploratory activity and escape‐seeking behavior , 2003, Genes, brain, and behavior.
[17] N. Moore,et al. Animal models of depression: are there any? , 2003, Human psychopharmacology.
[18] Brigitta B. Gundersen,et al. Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression , 2004, Neuropsychopharmacology.
[19] S. Nomura,et al. A new behavioral test for antidepressant drugs. , 1982, European journal of pharmacology.
[20] J. Crabbe,et al. Genetics of mouse behavior: interactions with laboratory environment. , 1999, Science.
[21] G. Koob,et al. Cellular and Behavioral Interactions of Gabapentin with Alcohol Dependence , 2008, The Journal of Neuroscience.
[22] M. Bourin,et al. The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice , 1996, Fundamental & clinical pharmacology.
[23] Cécile Béguin,et al. Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats , 2006, Journal of Pharmacology and Experimental Therapeutics.
[24] M. Vaswani,et al. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[25] G. Griebel,et al. 4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related , 2002, The Journal of pharmacology and experimental therapeutics.
[26] M. Bourin,et al. Involvement of 5-HT2C receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice , 2001, European Neuropsychopharmacology.
[27] C. Grillon,et al. Morphine pretreatment reduces clomipramine effect in mouse forced-swimming test. , 1983, European journal of pharmacology.
[28] M. Hascöet,et al. Brain structures implicated in the four-plate test in naïve and experienced Swiss mice using injection of diazepam and the 5-HT2A agonist DOI , 2009, Behavioural Brain Research.
[29] Michel Bourin,et al. Forced swimming test in mice: a review of antidepressant activity , 2004, Psychopharmacology.
[30] G. Woodruff,et al. The behavioural properties of CI‐988, a selective cholecystokininB receptor antagonist , 1991, British journal of pharmacology.
[31] R. Hen,et al. Altered Emotional States in Knockout Mice Lacking 5-HT1A or 5-HT1B Receptors , 1999, Neuropsychopharmacology.
[32] C. Bell,et al. Tryptophan depletion and its implications for psychiatry , 2001, British Journal of Psychiatry.
[33] A. Saria,et al. Different behavioral profiles of the non-peptide substance P (NK1) antagonists CP-96,345 and RP 67580 in Swiss albino mice in the black-and-white box , 1993, Neuroscience Letters.
[34] M. Millan,et al. The neurobiology and control of anxious states , 2003, Progress in Neurobiology.
[35] M. Bourin,et al. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity , 1998, Psychopharmacology.
[36] G. Griebel. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. , 1995, Pharmacology & therapeutics.
[37] A. M. Scotto di Tella,et al. [Influence of the procedure of administration in the activity of some antidepressant or disinhibiting drugs upon behavioural despair (author's transl)]. , 1981, Journal de pharmacologie.
[38] A. Rex,et al. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety , 1994, Neuroscience Letters.
[39] J. Kan,et al. Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug. , 1982, Arzneimittel-Forschung.
[40] B. Roques,et al. Opioid and CCK Systems in Anxiety and Reward , 1995 .
[41] M. Hascöet,et al. Anticonflict Effect of Alpidem as Compared with the Benzodiazepine Alprazolam in Rats , 1997, Pharmacology Biochemistry and Behavior.
[42] M. Hascöet,et al. Anxiolytic-Like Effects of Antidepressants After Acute Administration in a Four-Plate Test in Mice , 2000, Pharmacology Biochemistry and Behavior.
[43] H. Westenberg,et al. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors , 2000, Acta psychiatrica Scandinavica. Supplementum.
[44] G. Griebel. Variability in the effects of 5-HT-related compounds in experimental models of anxiety: evidence for multiple mechanisms of 5-HT in anxiety or never ending story? , 1996, Polish journal of pharmacology.
[45] A. Eschalier,et al. Influence of naloxone on antidepressant drug effects in the forced swimming test in mice , 2004, Psychopharmacology.
[46] R. Porsolt. Animal Models of Depression: Utility for Transgenic Research , 2000, Reviews in the neurosciences.
[47] D. Nutt,et al. Invited review: the evolution of antidepressant mechanisms , 2004, Fundamental & clinical pharmacology.
[48] M. Detke,et al. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth , 1995, Behavioural Brain Research.
[49] R. Porsolt,et al. Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. , 1979, European journal of pharmacology.
[50] P. Mandel,et al. Minaprine, a new drug with antidepressant properties. , 1985, Drugs under experimental and clinical research.
[51] C. Kuo,et al. Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones , 1997, British journal of pharmacology.
[52] S. Stahl,et al. Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. , 2008, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[53] J. Deakin,et al. Effects of ritanserin on aversive classical conditioning in humans , 2005, Psychopharmacology.
[54] M. Cador,et al. Effects of morphine and naloxone on behaviour in the hot plate test: an ethopharmacological study in the rat , 2005, Psychopharmacology.
[55] M. Hascöet,et al. Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test. , 2005, Journal of psychiatry & neuroscience : JPN.
[56] M. Bourin,et al. Pharmacotherapy of anxious disorders , 2002, Human psychopharmacology.
[57] M. Hascöet,et al. Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test , 2005, Psychopharmacology.
[58] D. Sanger,et al. The effects of NMDA antagonists on punished exploration in mice , 1991, Behavioural pharmacology.
[59] R. Porsolt,et al. "Behavioural despair" in rats and mice: strain differences and the effects of imipramine. , 1978, European journal of pharmacology.
[60] D. David,et al. Comparison of antidepressant activity in 4- and 40-week-old male mice in the forced swimming test: involvement of 5-HT1A and 5-HT1B receptors in old mice , 2001, Psychopharmacology.
[61] C. Goodchild,et al. gamma-Aminobutyric acidA receptors and spinally mediated antinociception in rats. , 1996, The Journal of pharmacology and experimental therapeutics.
[62] M. Bourin,et al. Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity. , 1991, Journal of psychiatry & neuroscience : JPN.
[63] Victor H. Denenberg,et al. A computer-aided procedure for measuring swim rotation , 1990, Physiology & Behavior.
[64] J. Hyttel. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) , 1994, International clinical psychopharmacology.
[65] C. Beyer,et al. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon , 2007, Neuropeptides.
[66] A. Wesołowska,et al. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression , 2007, Neuropharmacology.
[67] R. Twyman,et al. Barbiturate regulation of kinetic properties of the GABAA receptor channel of mouse spinal neurones in culture. , 1989, The Journal of physiology.
[68] M. Eller,et al. Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test. , 2009, European journal of pharmacology.
[69] W. A. Prado,et al. An assessment of the antinociceptive and aversive effects of stimulating identified sites in the rat brain , 1985, Brain Research.
[70] S. Kõks,et al. Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies , 2001, Physiology & Behavior.
[71] R. Post,et al. Mechanisms of Action of Anticonvulsants in Affective Disorders: Comparisons with Lithium , 1992, Journal of clinical psychopharmacology.
[72] J. Cryan,et al. Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission , 2008, Behavioural pharmacology.
[73] I. Lucki. Serotonin receptor specificity in anxiety disorders. , 1996, The Journal of clinical psychiatry.
[74] M. Bourin,et al. Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate , 1998, European Neuropsychopharmacology.
[75] K. Hole,et al. Benzodiazepine-induced antagonism of opioid antinociception may be abolished by spinalization or blockade of the benzodiazepine receptor , 1990, Pharmacology Biochemistry and Behavior.
[76] M. Hascöet,et al. Anxiolytic-like effect of milnacipran in the four-plate test in mice: Mechanism of action , 2005, Pharmacology Biochemistry and Behavior.
[77] M. Naoi,et al. Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice , 1996, Pharmacology Biochemistry and Behavior.
[78] E. Mogilnicka,et al. Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action. , 1987, European journal of pharmacology.
[79] M. Bourin,et al. Influence of Prior Experience on Mice Behavior Using the Four-Plate Test , 1997, Pharmacology Biochemistry and Behavior.
[80] H. Iwata,et al. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin. , 1998, The Journal of pharmacology and experimental therapeutics.
[81] T. Umezu. Effects of psychoactive drugs in the Vogel conflict test in mice. , 1999, Japanese journal of pharmacology.
[82] S. Maier,et al. Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock , 1984, Pharmacology Biochemistry and Behavior.
[83] M. Hascöet,et al. Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety , 2003, Behavioural Brain Research.
[84] S. Ikemoto,et al. Social isolation effects on the “behavioral despair” forced swimming test: Effect of age and duration of testing , 1991, Physiology & Behavior.
[85] S. Kulkarni,et al. GABA-mediated modification of despair behavior in mice , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[86] M. Bourin,et al. Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. , 1992, Journal of psychiatry & neuroscience : JPN.
[87] W. Pakulska,et al. Effect of diazepam and midazolam on the antinociceptive effect of morphine, metamizol and indomethacin in mice. , 2001, Die Pharmazie.
[88] R. Ring,et al. Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications , 2006, Psychopharmacology.
[89] G. Szymczyk,et al. Influence of antiepileptics on efficacy of antidepressant drugs in forced swimming test. , 2000, Polish journal of pharmacology.
[90] A. Wesołowska,et al. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression , 2006, Neuropharmacology.
[91] B. Costall,et al. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[92] C. Chopde,et al. Behavioral action of ethanol in Porsolt’s forced swim test: modulation by 3alpha-hydroxy-5alpha-pregnan-20-one , 2002, Neuropharmacology.
[93] G. Skuza,et al. Pharmacological profile of milnacipran, a new antidepressant, given acutely. , 1999, Polish journal of pharmacology.
[94] P. Rocca,et al. Paroxetine efficacy in the treatment of generalized anxiety disorder , 1997, Acta psychiatrica Scandinavica.
[95] J. Siuciak,et al. Antidepressant-Like Effect of Brain-derived Neurotrophic Factor (BDNF) , 1997, Pharmacology Biochemistry and Behavior.
[96] Y. Kiuchi,et al. Antinociceptive efficacy of antidepressants: assessment of five antidepressants and four monoamine receptors in rats , 2001, Journal of Anesthesia.
[97] Antonio Alcaro,et al. Genotype- and experience-dependent susceptibility to depressive-like responses in the forced-swimming test , 2002, Psychopharmacology.
[98] E. Tatarczyńska,et al. The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist. , 2004, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[99] K. Chopra,et al. Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. , 2003, Journal of medicinal food.
[100] E. F. Espejo,et al. Structure of the rat's behaviour in the hot plate test , 1993, Behavioural Brain Research.
[101] M. Volosin,et al. Corticosterone influences forced swim-induced immobility , 1994, Pharmacology Biochemistry and Behavior.
[102] R. Post,et al. Antidepressant effects of carbamazepine. , 1986, The American journal of psychiatry.
[103] M. Hascöet,et al. The influence of buspirone, and its metabolite 1-PP, on the activity of paroxetine in the mouse light/dark paradigm and four plates test , 2000, Pharmacology Biochemistry and Behavior.
[104] 奥田 圭子. Trazodone hydrochloride attenuates thermal hyperalgesia in a chronic constriction injury rat model , 2002 .
[105] E. Kiyatkin,et al. Severe brain hypothermia as a factor underlying behavioral immobility during cold-water forced swim , 2003, Brain Research.
[106] P. Skolnick,et al. Intra- and interstrain differences in models of “behavioral despair” , 2001, Pharmacology Biochemistry and Behavior.
[107] C. Beyer,et al. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders , 2008, Psychopharmacology.
[108] Richard Graham Knowles,et al. Inhibition by Lamotrigine of the Generation of Nitric Oxide in Rat Forebrain Slices , 1995, Journal of neurochemistry.
[109] M. Hascöet,et al. The four-plates test: Anxiolytic or analgesic paradigm? , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[110] M. Bourin,et al. Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems , 1996, European Neuropsychopharmacology.
[111] S. Schreiber,et al. The antinociceptive effect of trazodone in mice is mediated through both μ-opioid and serotonergic mechanisms , 2000, Behavioural Brain Research.
[112] Andrzej Pilc,et al. Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models , 1999, Neuropharmacology.
[113] M. Barrot,et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[114] I. Lucki,et al. Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. , 2001, The Journal of pharmacology and experimental therapeutics.
[115] M. Hascöet,et al. Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test , 2005, Psychopharmacology.
[116] M. Bourin,et al. A schematic representation of the psychopharmacological profile of antidepressants , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[117] M. Bourin,et al. Antidepressant-like effect of lamotrigine is reversed by veratrine: A possible role of sodium channels in bipolar depression , 2008, Behavioural Brain Research.
[118] D. David,et al. Antidepressant-like effects in various mice strains in the forced swimming test , 2003, Psychopharmacology.
[119] M. Bourin. Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests? , 1990, Fundamental & clinical pharmacology.
[120] Takeo Yoshikawa,et al. Identification of multiple genetic loci linked to the propensity for "behavioral despair" in mice. , 2002, Genome research.
[121] M. Hascöet,et al. The four-plates test–retest paradigm to discriminate anxiolytic effects , 2005, Psychopharmacology.
[122] Jan Passchier,et al. Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system , 2001, European Journal of Nuclear Medicine.
[123] E. Przegaliński,et al. Anxiolytic- and antidepressant-like effects of an antagonist at glycineB receptors. , 1998, Polish journal of pharmacology.
[124] M. Hascöet,et al. Implication of 5-HT2A subtype receptors in DOI activity in the four-plates test–retest paradigm in mice , 2006, Behavioural Brain Research.
[125] Douglas Wahlsten,et al. Different data from different labs: lessons from studies of gene-environment interaction. , 2003, Journal of neurobiology.
[126] F. Borsini,et al. The effect of DAU 6215, a novel 5HT-3 antagonist, in animal models of anxiety. , 1993, Pharmacological research.
[127] T. Hata,et al. Behavioral characteristics of SART-Stressed mice in the forced swim test and drug action , 1995, Pharmacology Biochemistry and Behavior.
[128] J. Gorman,et al. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression. , 1999, The Journal of clinical psychiatry.
[129] W. Chance,et al. Non-specificity of "behavioral despair" as an animal model of depression. , 1979, European journal of pharmacology.
[130] A. Eschalier,et al. Naloxone inhibits clomipramine in mouse forced swimming test. , 1982, European journal of pharmacology.
[131] M. Hascöet,et al. α2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice , 2005, Behavioural Brain Research.
[132] N. Cosford,et al. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling. , 2004, Neuropharmacology.
[133] J. Feighner. Overview of antidepressants currently used to treat anxiety disorders. , 1999, The Journal of clinical psychiatry.
[134] M. Bourin,et al. How valuable are animal models in defining antidepressant activity? , 2001, Human psychopharmacology.
[135] M. Kołaczkowski,et al. Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity. , 2010, European journal of medicinal chemistry.
[136] M. P. McDonald,et al. The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[137] I. Lucki. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. , 1997, Behavioural pharmacology.
[138] M. Rutkowska,et al. Effects of Cannabinoids on the Anxiety-like Response in Mice , 2022 .
[139] G. Perrault,et al. A Comparative Study of the Effects of Selective and Non-Selective 5-HT2 Receptor Subtype Antagonists in Rat and Mouse Models of Anxiety , 1997, Neuropharmacology.
[140] T. Feuerstein,et al. Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. , 1993, Arzneimittel-Forschung.
[141] J. Kocsis,et al. A summary of mechanistic hypotheses of gabapentin pharmacology , 1998, Epilepsy Research.
[142] I. Lucki,et al. Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects , 2007, Neuropsychopharmacology.
[143] F. Gasparini,et al. Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist , 2001, British journal of pharmacology.
[144] Ronald G. Browne. Effects of antidepressants and anticholinergics in a mouse "behavioral despair" test. , 1979, European journal of pharmacology.
[145] M. Hascöet,et al. Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system , 1994, Psychopharmacology.
[146] I. Lucki,et al. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice , 2001, Psychopharmacology.
[147] M. Barrot,et al. Brain-derived neurotrophic factor in the ventral midbrain–nucleus accumbens pathway: a role in depression , 2003, Biological Psychiatry.
[148] T. Krahe,et al. Effects of rotational side preferences on immobile behavior of normal mice in the forced swimming test , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[149] M. Dubocovich,et al. Antidepressant-like activity of the melatonin receptor antagonist, luzindole (N-0774), in the mouse behavioral despair test. , 1990, European journal of pharmacology.
[150] Philip S. Portoghese,et al. Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.
[151] T. Gould,et al. The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics , 2007, Neuroscience & Biobehavioral Reviews.
[152] M. Corsi,et al. Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse , 2003, Neuroscience Letters.
[153] Chieh-fu Chen,et al. Anxiolytic-like effects of baicalein and baicalin in the Vogel conflict test in mice. , 2003, European journal of pharmacology.
[154] S. Kulkarni,et al. Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation , 2000, European Neuropsychopharmacology.
[155] R. Porsolt,et al. Behavioral despair in mice: a primary screening test for antidepressants. , 1977, Archives internationales de pharmacodynamie et de therapie.
[156] M. Hascöet,et al. Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[157] P. Jolliet,et al. Evidence for a 5-HT2A receptor mode of action in the anxiolytic-like properties of DOI in mice , 2003, Behavioural Brain Research.
[158] S. Maier,et al. Opioid and nonopioid interactions in two forms of stress-induced analgesia , 1993, Pharmacology Biochemistry and Behavior.
[159] B. Costall,et al. The selective sigma2-ligand Lu 28-179 has potent anxiolytic-like effects in rodents. , 1997, The Journal of pharmacology and experimental therapeutics.
[160] P. Simon,et al. A new method for rapid screening of minor tranquillizers in mice. , 1968, European journal of pharmacology.
[161] D. David,et al. Antidepressant-like effects in various mice strains in the tail suspension test , 2003, Behavioural Brain Research.
[162] G. MacQueen,et al. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. , 2001, Behavioral neuroscience.
[163] S. Hunskaar,et al. Antinociceptive effects of serotonergic reuptake inhibitors in mice , 1989, Neuropharmacology.
[164] I. Paul,et al. Group housing of mice increases immobility and antidepressant sensitivity in the forced swim and tail suspension tests. , 2001, European journal of pharmacology.
[165] S. Cabib,et al. The contribution of comparative studies in inbred strains of mice to the understanding of the hyperactive phenotype , 2002, Behavioural Brain Research.
[166] E. Gould,et al. Preclinical models: status of basic research in depression , 2002, Biological Psychiatry.
[167] A. West. Neurobehavioral studies of forced swimming: The role of learning and memory in the forced swim test , 1990, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[168] M. Briley,et al. Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-amino-carbonyl-2-aminomethylcyclopropane hydrochloride (F 2207), a new potential antidepressant , 2004, Psychopharmacology.
[169] P. Chopin,et al. Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission , 1987 .
[170] B. J. Cole,et al. Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies , 1994, Psychopharmacology.
[171] Y. Kitamura,et al. Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test , 2002, Pharmacology Biochemistry and Behavior.
[172] M. Hascöet,et al. Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test , 2007, Behavioural Brain Research.
[173] A. Meli,et al. Is the forced swimming test a suitable model for revealing antidepressant activity? , 2004, Psychopharmacology.
[174] A. Puech,et al. Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice , 1997, Journal of psychopharmacology.
[175] B. Cooper,et al. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. , 1980, The Journal of pharmacology and experimental therapeutics.
[176] S. Otomo,et al. Decreased body temperature dependent appearance of behavioral despair in the forced swimming test in mice. , 2000, Pharmacological research.
[177] G. Wegener,et al. Increased extracellular serotonin level in rat hippocampus induced by chronic citalopram is augmented by subchronic lithium: neurochemical and behavioural studies in the rat , 2003, Psychopharmacology.
[178] G. Sills. The mechanisms of action of gabapentin and pregabalin. , 2006, Current opinion in pharmacology.
[179] S. Woods,et al. Serotonin function in anxiety , 1987, Psychopharmacology.